Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 12472
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 133nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 233nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 247nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 285nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 324nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 336nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 369nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 393nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 424nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 432nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 436nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 436nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 449nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 488nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 489nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 533nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 540nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 555nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 648nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 691nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 782nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 787nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 799nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 907nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 944nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 991nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 998nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.01E+3nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.21E+3nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.35E+3nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.80E+3nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.83E+3nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 1.92E+3nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair
TargetEgl nine homolog 1/Hypoxia-inducible factor 1-alpha [788-822](Human)
China Pharmaceutical University
US Patent
China Pharmaceutical University
US Patent
Affinity DataIC50: 2.90E+4nMAssay Description:The ability of the compounds to compete with a fluorophore-labeled HIF-la peptide fragment (FITC-HIF-1α 788-822) for binding to the PHD2 protein was ...More data for this Ligand-Target Pair

































